Article thumbnail

Leucine-Rich Repeat Kinase 2 Modulates Retinoic Acid-Induced Neuronal Differentiation of Murine Embryonic Stem Cells

By Cathrin Schulz, Marie Paus, Katharina Frey, Ramona Schmid, Zacharias Kohl, Detlev Mennerich, Jürgen Winkler and Frank Gillardon
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2007). A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body disease.
  2. (2010). A comparative study of Lrrk2 function in primary neuronal cultures. Parkinsonism Relat Disord.
  3. (2004). affy–analysis of Affymetrix GeneChip data at the probe level.
  4. (2008). Alphasynuclein alters Notch-1 expression and neurogenesis in mouse embryonic stem cells and in the hippocampus of transgenic mice.
  5. (2010). ArrayExpress update–an archive of microarray and high-throughput sequencing-based functional genomics experiments. Nucleic Acids Res.
  6. (2004). Bioconductor: open software development for computational biology and bioinformatics.
  7. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing.
  8. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells.
  9. (2002). Developmental neurotransmitters?
  10. (2004). Differentiation of mouse embryonic stem cells into a defined neuronal lineage.
  11. (2008). Embryonic stem cell-derived neurons as a cellular system to study gene function: lack of amyloid precursor proteins APP and APLP2 leads to defective synaptic transmission.
  12. (2010). Expression of leucinerich-repeat-kinase 2 (LRRK2) during embryonic development.
  13. (2003). Expression profiling of epithelial plasticity in tumor progression.
  14. (2004). Expression profiling of mammalian microRNAs uncovers a subset of brainexpressed microRNAs with possible roles in murine and human neuronal differentiation.
  15. (2007). Generation of a defined and uniform population of CNS progenitors and neurons from mouse embryonic stem cells.
  16. (2008). Global transcription in pluripotent embryonic stem cells.
  17. (2010). Impact of actin filament stabilization on adult hippocampal and olfactory bulb neurogenesis.
  18. (1998). Impaired locomotion and dopamine signaling in retinoid receptor mutant mice.
  19. (2009). Leucine-rich repeat kinase 2 phosphorylates brain tubulinbeta isoforms and modulates microtubule stability–a point of convergence in parkinsonian neurodegeneration?
  20. (2005). Limma: linear models for microarray data. In:
  21. (2010). Lin28: A microRNA regulator with a macro role.
  22. (2004). Linear models and empirical bayes methods for assessing differential expression in microarray experiments.
  23. (2006). Localization of LRRK2 to membranous and vesicular structures in mammalian brain.
  24. (2006). LRRK2 in Parkinson’s disease: protein domains and functional insights.
  25. (2007). LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson’s disease mutants affect kinase activity.
  26. (2010). New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?
  27. (2010). Opposing microRNA families regulate self-renewal in mouse embryonic stem cells.
  28. (2006). Parkinsonism genes: culprits and clues.
  29. (2010). Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression.
  30. (2008). Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila.
  31. (2009). Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis.
  32. (2007). Physical activity fails to rescue hippocampal neurogenesis deficits in the R6/2 mouse model of Huntington’s disease.
  33. (2007). Protein kinases and the proteasome join in the combinatorial control of transcription by nuclear retinoic acid receptors.
  34. (2009). R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice.
  35. (1999). Regulation of F-actin binding to platelet moesin in vitro by both phosphorylation of threonine 558 and polyphosphatidylinositides.
  36. (2005). Regulatory networks in embryo-derived pluripotent stem cells.
  37. (2007). Retinoic acid in the development, regeneration and maintenance of the nervous system.
  38. (2010). Retinoid6receptor gamma control of affective behaviors involves dopaminergic signaling in mice.
  39. (2006). RORalphamediated Purkinje cell development determines disease severity in adult SCA1 mice.
  40. (2003). Summaries of Affymetrix GeneChip probe level data.
  41. (1988). The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis.
  42. (2009). The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro.
  43. (2008). Update on the functional biology of Lrrk2.